Evidence map›Paper›PMID 19279090›Full record

ArticleJournal of virology2009

The receptor complex associated with human T-cell lymphotropic virus type 3 (HTLV-3) Env-mediated binding and entry is distinct from, but overlaps with, the receptor complexes of HTLV-1 and HTLV-2.

Kathryn S Jones, Ying K Huang, Sébastien A Chevalier, Philippe V Afonso, Cari Petrow-Sadowski, Daniel C Bertolette, Antoine Gessain, Francis W Ruscetti, Renaud Mahieux

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Kathryn S JonesBasic Science Program, SAIC-Frederick, National Cancer Institute-Frederick, Frederick, MD 21702-1201, USA. joneska@mail.nih.gov
Ying K Huang
Sébastien A Chevalier
Philippe V Afonso
Cari Petrow-Sadowski
Daniel C Bertolette
Antoine Gessain
Francis W Ruscetti
Renaud Mahieux
Institut Pasteur · FRCenter for Cancer Research · USScience Applications International Corporation (United States) · US

Funding

Pathogenic Effects of Human Retroviruses on Hematopoietic and Adherent Cells.ZIABC010252 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI RUSCETTI, FRANCIS W · 2009 to 2013
$5.1M
Intramural NIH HHSNCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400
6 · The paper itself

Abstract

Little is known about the transmission or tropism of the newly discovered human retrovirus, human T-cell lymphotropic virus type 3 (HTLV-3). Here, we examine the entry requirements of HTLV-3 using independently expressed Env proteins. We observed that HTLV-3 surface glycoprotein (SU) binds efficiently to both activated CD4(+) and CD8(+) T cells. This contrasts with both HTLV-1 SU, which primarily binds to activated CD4(+) T cells, and HTLV-2 SU, which primarily binds to activated CD8(+) T cells. Binding studies with heparan sulfate proteoglycans (HSPGs) and neuropilin-1 (NRP-1), two molecules important for HTLV-1 entry, revealed that these molecules also enhance HTLV-3 SU binding. However, unlike HTLV-1 SU, HTLV-3 SU can bind efficiently in the absence of both HSPGs and NRP-1. Studies of entry performed with HTLV-3 Env-pseudotyped viruses together with SU binding studies revealed that, for HTLV-1, glucose transporter 1 (GLUT-1) functions at a postbinding step during HTLV-3 Env-mediated entry. Further studies revealed that HTLV-3 SU binds efficiently to naive CD4(+) T cells, which do not bind either HTLV-1 or HTLV-2 SU and do not express detectable levels of HSPGs, NRP-1, and GLUT-1. These results indicate that the complex of receptor molecules used by HTLV-3 to bind to primary T lymphocytes differs from that of both HTLV-1 and HTLV-2.

Indexed as

Amino Acid SequenceCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell LineDeltaretrovirusDeltaretrovirus AntigensGene Products, envGlucose Transporter Type 1Heparan Sulfate ProteoglycansHumansMolecular Sequence DataPhylogenyProtein BindingReceptors, VirusSequence AlignmentTransduction, GeneticDeltaretrovirus AntigensGene Products, envGlucose Transporter Type 1Heparan Sulfate ProteoglycansReceptors, Virus

Identifiers

PMID19279090
PMCPMC2682092
OpenAlexW2131037992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.